TrialCancer research and treatment2018

Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study.

Ki Sun Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.